Monte Rosa Therapeutics
GLUE
#6712
Rank
NZ$1.34 B
Marketcap
NZ$15.79
Share price
-3.03%
Change (1 day)
-37.63%
Change (1 year)

EPS for Monte Rosa Therapeutics (GLUE)

EPS in 2026 (TTM): NZ-$2.97

According to Monte Rosa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$3.12. In 2025 the company made an earnings per share (EPS) of NZ-$1.41 an increase over its 2024 EPS that were of NZ-$1.89.

EPS history for Monte Rosa Therapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.97110.33%
2025NZ-$1.41-25.22%
2024NZ-$1.89-60.93%
2023NZ-$4.8315.28%
2022NZ-$4.19